Set to Climb Greater Heights – Driven by a Passion for Excellence
Jamjoom Pharma has proudly completed 17 years of very successful operations. It is one of the recognized leaders of the regional Pharmaceutical industry. Products offered by the company are currently reaching 28 countries in the region.
The Pharma division of the company focuses on several therapeutic categories such as Ophtha, Derma, GIT, Cardio Vascular, General Medicines. The Consumer Health Division setup in 2014, handles Nutraceuticals and OTC products.
Jamjoom Pharma has deservedly earned a reputation for exceptional quality of products. Investment in top class manufacturing technology, accompanied by constant upgradations have ensured a world class manufacturing facility comparable to the best. The first softgel manufacturing facility in the region, a world class investment, has already undergone expansion. Jamjoom Pharma has targeted to carve out a leadership position in the regional Dietary Supplements market. These supplements are pharma grade products and unquestionably Halal.
The company has commissioned in 2016 a new tablets and capsules manufacturing facility with the latest equipment which can be rated among the best in the global Pharma industry. New manufacturing venture is being set up in Egypt to meet the fast growing demand from countries in African market. Company is also setting up a joint venture in Algeria. Market entry into Turkey is planned in 2017 by implementing local manufacturing arrangement for the Ophthalmic range.
Jamjoom Pharma supports sustainable development and constantly strives to fulfill corporate social responsibilities. Glaucoma detection programs have been implemented in parts of Africa. Jamjoom Academy in Jeddah is on the drawing board, expected to be completed by 2018. This will contribute to upgrading the skills and knowledge of Saudi nationals in the Pharma sector.
